Management of CKD in Diabetes: Putting Evidence into Practice
The availability of SGLT2i has revolutionised the management of chronic kidney disease and diabetes. Join us on Thursday, 20 July 2023 from 7:00 pm to 8:00 pm (AEST) as we […]
The availability of SGLT2i has revolutionised the management of chronic kidney disease and diabetes. Join us on Thursday, 20 July 2023 from 7:00 pm to 8:00 pm (AEST) as we […]
The ADS John R Turtle Diabetes Clinical Skills Training Course is designed to be practical and interactive. It will be run by experienced diabetes clinicians from across Australia and will […]
Join us on Thursday, 14 September 2023 from 7:00 pm to 8:00 pm (AEST) as we discuss trials, guidelines and treatments relating to heart failure and diabetes. Discussion points include: […]
Live Panel Discussion Join our panel of experts on Monday, 13 November 2023 from 7:00 pm to 8:00 pm (AEDT) as they discuss the outcomes of the American Heart Association […]
Join us on Thursday, 23 November 2023 from 7:00 pm to 8:00 pm (AEDT) as we discuss the following in relation to the role of SGLT2 inhibitors in type 2 […]
The Australian Diabetes Society is running its annual Practical Skills Course for First Year Trainees in Adult Endocrinology over two days with the first day held on Saturday 17th February 2024 from 8.00am to 6.15pm (AEDT) at the Crowne Plaza […]
Live Panel Discussion The use of GLP-1 agonists are revolutionising the care of type 2 diabetes and chronic kidney disease. Join us on Monday, 27 May 2024 from 7:00 pm to […]
21-24 June 2024 Join us as we bring you the latest highlights from the American Diabetes Association (ADA) 84th Scientific Sessions in Orlando, FL, USA, taking place 21-24 June 2024! The […]
Saturday, 6th July 2024 | 9:00am to 5:30pm (AEST) Online Virtual Event The John R Turtle Diabetes Clinical Skills Training Course is designed to be practical and interactive. It will […]
Join us on Thursday, 25 July 2024 from 7:00 pm to 8:00 pm (AEST) as we discuss the following in relation to the benefits of SGLT2 inhibitors in diabetes management: Role […]
Each day in Australia, an estimated 510,000 people are living with diabetes-related foot disease, and it has been described in the Medical Journal of Australia as the ‘least known major […]
Join us on Thursday, 5 December 2024 from 7:00 pm to 8:00 pm (AEDT) as we discuss the latest trials on the management of MASH in people with and without diabetes. […]